Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pharmacogenetic Testing clinical trials
A small indexed set (3 trials) with no open enrollment listed right now.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · none currently recruiting · #5,209 of 28,707 conditions by registered trial count
Pharmacogenetic Testing: 3 US clinical trials tracked, none currently recruiting.
Pharmacogenetic Testing is the subject of 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Seattle Institute for Biomedical and Clinical Research, running 1 of these trials.
Enrollment posture brief
Registry condition pharmacogenetic-testing
OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Pharmacogenetic Testing has no open enrollment in this registry pull (3 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pharmacogenetic Testing on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pharmacogenetic Testing is recruiting below its size-band peers.
0 of 3 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
3 total, page 1 of 1
Trial of Preemptive Pharmacogenetics in Underserved Patients
University of Florida
NCT05141019
Pharmacogenetic Testing in Primary Care
Duke University
NCT01600846
Medication Optimization Using Pharmacogenetic Testing and the G-DIG to Reduce Polypharmacy in a Mental Health Population
Seattle Institute for Biomedical and Clinical Research
NCT03468309
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Pharmacogenetic Testing records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pharmacogenetic Testing trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pharmacogenetic Testing page
3 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Pharmacogenetic Testing trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Seattle Institute for Biomedical and Clinical Research sponsors the most Pharmacogenetic Testing trials on record, review their full trial history before evaluating a specific study. See Seattle Institute for Biomedical and Clinical Research's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pharmacogenetic Testing condition card totals 3 registered trials; most-linked intervention Genecept Assay and G-DIG decision tool; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.